Palaniyandi Velusamy | Drug Discovery and Development |

Published on by Top Pharmaceutical

Prof. Dr. Palaniyandi Velusamy | Drug Discovery and Development | Research Excellence Award

Sree Balaji Medical College and Hospital  | India

Prof. Dr. Palaniyandi Velusamy is a distinguished researcher, academic leader, and biotechnology expert recognized for his extensive contributions to microbiology, nanobiotechnology, biosciences, and antibacterial drug research. He began his academic journey with foundational studies in botany and biochemistry before completing his doctoral research at the University of Madras, where he specialized in antibacterial agents and developed research competencies that shaped his future scientific pursuits. Following his Ph.D., he undertook multiple prestigious post-doctoral fellowships across internationally reputed institutions in Taiwan and South Korea, including Academia Sinica, Korea University, and Chonnam National University, where he contributed to advanced research in nanotechnology, microbial applications, and bioengineering. He later served as a Visiting Professor at Kyung Hee University in South Korea, strengthening his global academic footprint. In India, he built a progressive academic career at SRM University, where he contributed as Assistant Professor, Associate Professor, and later took on key departmental responsibilities including Deputy Controller of Examinations, Research Coordinator, Department Treasurer, Class In-Charge for B.Tech and M.Tech programs, Counsellor, and Course Coordinator for key subjects such as Microbial Technology, Microbiology, Enzyme Technology, Bionanotechnology, Green Chemistry, Pharmaceutical Engineering, and Phytochemistry. His academic leadership expanded further when he joined Sree Balaji Medical College and Hospital, Chennai, where he served as Professor and currently holds the role of Joint Director at the Innovation & Incubation Centre, guiding institutional innovation, research development, and technology incubation.Prof. Velusamy’s contributions to scientific publishing are extensive; he serves as Editor for Scientific Reports (Nature Publishing Group), Associate Editor for Frontiers in Bioengineering and Biotechnology, Editor for the Global Journal of Pathology and Microbiology, Guest Editor for Biosensors, and Editorial Board Member for the Austin Journal of Nanomedicine & Nanotechnology. He is also an invited reviewer for globally recognized journals including Colloids and Surfaces B, Spectrochimica Acta Part A, Heliyon, and the International Journal of Biological Macromolecules.

Profile: Orcid

Featured Publications

Krishnan, N., Singh, P. K., Sakthivelu, M., Velusamy, P., Gopinath, S. C. B., & Raman, P. (2024). Influence of thermal treatment on extraction and characteristics of phytochemicals from rhizome of _Acorus calamus L_. Biomass Conversion and Biorefinery. doi:10.1007/s13399-022-03415-y

Velusamy, P., Jeyanthi, V., Pachaiappan, R., Anbu, P., & Gopinath, S. C. B. (2024). Secretion of 2,4‑di‑tert‑butylphenol by a new _Pseudomonas strain SBMCH11: A tert‑butyl substituted phenolic compound displayed antibacterial efficacy_. Results in Chemistry, 6, 101593. doi:10.1016/j.rechem.2024.101593

Velusamy, P., Su, C.-H., Ramasamy, P., Arun, V., Rajnish, N., Raman, P., Baskaralingam, V., Kumar, S. M. S., & Gopinath, S. C. B. (2023). Volatile Organic Compounds as Potential Biomarkers for Noninvasive Disease Detection by Nanosensors: A Comprehensive Review. Critical Reviews in Analytical Chemistry, 53(4), 1‑30. doi:10.1080/10408347.2022.2043145

Soundararajan, P., Parthasarathy, S., Sakthivelu, M., Karuppiah, K. M., Velusamy, P., Gopinath, S. C. B., & Raman, P. (2023). Effects of Consuming Repeatedly Heated Edible Oils on Cardiovascular Diseases: A Narrative Review. Current Medicinal Chemistry, 30(30), 1‑18. doi:10.2174/0109298673250752230921090452

Ramesh, V., Kulkarni, S. A., Velusamy, P., Devadasan, V., Devaraju, P., Rajnish, K. N., Madhavan, T., Anbu, P., Ramasamy, P., & Sundarraj, R. (2022). Current Update of Phytotherapeutic Agents in the Treatment of COVID‑19: <i>In‑Silico</i> Based Virtual Screening Approach for the Development of Antiviral Drug. Frontiers in Bioscience‑Landmark, 27(4), 123. doi:10.31083/J.FBL2704123

Parthasarathy, S., Soundararajan, P., Krishnan, N., Karuppiah, K. M., Devadasan, V., Prabhu, D., Rajamanikandan, S., Velusamy, P., Gopinath, S. C. B., & Raman, P. (2022). Detection of adulterants from common edible oils by GC‑MS. Biomass Conversion and Biorefinery, 12(5), 1‑12. doi:10.1007/S13399-022-02913-3

Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Liaoning University of Traditional Chinese Medicine | China

Prof. Xiangxuan Zhao is a distinguished cell biologist and an eminent academic leader renowned for his pioneering contributions to the field of natural medicine-derived anti-cancer therapeutics. Serving as Professor, Doctoral Supervisor, and Postdoctoral Mentor, he holds prestigious positions as the Dean of the College of Laboratory Animal Medicine and Director of the Laboratory Animal Center at the Liaoning University of Traditional Chinese Medicine in Shenyang, China. With a career dedicated to advancing the frontiers of cancer biology and pharmaceutical innovation, Prof. Zhao has established himself as a leading authority in tumor drug resistance mechanisms, molecular target discovery, molecular targeted drug development, and tumor immunotherapy research.Prof. Zhao’s academic journey reflects a blend of scientific rigor and innovative leadership. Prior to his current roles, he contributed significantly as Deputy Director of the Engineering Technology Center for TCM Innovation at Liaoning University of Traditional Chinese Medicine and as a Researcher at the Health Science Research Institute of China Medical University. His earlier tenure as an Associate Researcher at Shengjing Hospital, China Medical University, laid the groundwork for his expertise in translational medicine, fostering a seamless bridge between laboratory research and clinical applications.A prolific scholar, Prof. Zhao has authored and co-authored eighty-four academic papers, including thirty-one SCI-indexed publications with a cumulative impact factor of one hundred eighty-eight. Among these, five papers boast impact factors exceeding ten, with his highest-impact publication reaching an impressive twenty-seven point four. His scientific excellence is further reflected in the thirteen national patents he holds, with four as the first inventor, underscoring his role as a trailblazer in molecular oncology and therapeutic innovation.

Profile: Orcid

Featured Publications

Liu, Y., Guo, R., Xue, C., Zhang, X., Xiao, F., Zhao, X., Zhu, Z., & Li, K. (2025). Phytosphingosine suppresses gastric cancer through SFRP4/β-catenin axis-mediated Wnt signaling pathway inhibition. Chemico-Biological Interactions.

Ke, W., Wang, H., Zhao, X., & Lu, Z. (2021). Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food & Function.

Sun, W., Ren, Y., Lu, Z., & Zhao, X. (2020). The potential roles of exosomes in pancreatic cancer initiation and metastasis. Molecular Cancer.

Ke, W., Zhao, X., & Lu, Z. (2020). Bcl-2 is essential for Foeniculum vulgare seed extract-induced apoptosis in lung cancer. Research Square.